Major Liver Resection in Cirrhotic HCC Patients in the Era of Robotic Surgery: Expanding Boundaries of Surgical Therapy
Clicks: 2
ID: 315718
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #84 of 432 articles by views in the british journal of surgery
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Cirrhosis has traditionally been considered a relative contraindication for hepatic resection due to the risk of post-hepatectomy liver failure (PHLF). With the rising incidence of HCC and persistent organ shortage, alternative curative approaches are urgently required. Robotic surgery may provide improved outcomes, less invasiveness, and be particularly beneficial for cirrhotic patients. Aims To evaluate the safety and outcomes of robotic liver resection in cirrhotic HCC patients. Methods We retrospectively analyzed all cirrhotic patients with HCC undergoing liver resection between 2020–2025. Patients were stratified by approach (open, laparoscopic, robotic). Results Fifty-seven (n=57) cirrhotic patients underwent liver resection for HCC: open (n=28), laparoscopic (n=7), and robotic (n=21). Whereas initially major resections accounted only for 17% (n=6/35) of open and laparoscopic resections, the initiation of the robotic program significantly increased the rate of major resections up to 43% (n=9/21). Despite a learning curve, overall median operative time was comparable between open and robotic resections (242 vs. 252 minutes, p=0.64), whereas robotic procedures significantly reduced operation time compared with equivalent laparoscopic resections from 214 to 198 minutes (p=0.03). With proportional increase of major liver resections, a trend to bigger tumor size and frameshift from BCLC 0 to BCLC A patients was observed for the robotic group. In that context, PHLF occurred in n=3/6 robotic major resections (all ISGLS grade A, resolved with supportive care) versus n=2/9 severe grade C cases after open surgery. Despite more complex resections, robotic patients had shorter ICU stay (1 vs. 3 days, p=0.01) and reduced hospital stay (7 vs. 11 days, p=0.02). No conversion and no mortality occured for robotic resections. R0 rates were comparable (98% vs. 96%, p=0.89). Conclusion Robotic hepatectomies are safe in selected cirrhotic HCC patients. Although mild PHLF was common, recovery outcomes are favorable. Therfore, in the era of organ shortage, robotic surgery can expand resectional options.
| Reference Key |
openalex_W7163340162
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | P Kambakamba, S Farkas |
| Journal | the british journal of surgery |
| Year | 2026 |
| DOI |
10.1093/bjs/znag055.034
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.